Positive news on phase 3 trials.
Possible US food & drug admin application next year 2025
8.5 times the usual 20 daily volume average.
Red to green reversal.
This all points towards likely higher prices. If their application next year gets approved expect a monster move. Investors will likely try to front run this.
